Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

BACKGROUND/AIMS: Treating hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) remains controversial. We compared the outcomes of hepatic resection (HR), transarterial chemoembolization (TACE), and sorafenib therapy as treatments for HCC with PVTT. METHODS: Patients diagnosed as H...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung Min, Jang, Byoung Kuk, Lee, Yoo Jin, Choi, Wang Yong, Choi, Sei Myong, Chung, Woo Jin, Hwang, Jae Seok, Kang, Koo Jeong, Kim, Young Hwan, Chauhan, Anil Kumar, Park, Soo Young, Tak, Won Young, Kweon, Young Oh, Kim, Byung Seok, Lee, Chang Hyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825165/
https://www.ncbi.nlm.nih.gov/pubmed/27044767
http://dx.doi.org/10.3350/cmh.2016.22.1.160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825165/
https://www.ncbi.nlm.nih.gov/pubmed/27044767
http://dx.doi.org/10.3350/cmh.2016.22.1.160

Ejemplares similares